OTA 2022: Long-Term Effect of Intra-operative Hip Fracture Injections on Pain and Function
The Long-Term Effect of Intraoperative Hip Fracture Injections (HiFI) on Function and Patient Reported Outcomes: A Randomized Controlled Trial
202 patients with hip fractures undergoing fracture fixation surgery were randomized to receive a multimodal pain injection to the fracture hematoma and operative site (n=82) or a no-injection control group (n=120). The primary outcomes of interest were inpatient pain levels, American Pain Society Patient Outcome Questionnaire (APS-POQ), ambulation distance, and length of stay. Secondary outcomes of interest included outpatient APS-POQ scores and the Short Musculoskeletal Function Assessment (SMFA) scores at 6 weeks post-surgery. The results of this study found that patients in the hip injection group reported significantly less inpatient and outpatient pain and function, better quality sleep, and higher levels of satisfaction compared to the control group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
